CASE STUDY| I thought it was safe
A middle-aged woman taking the breast cancer drug Tamoxifen for ten years became concerned when she saw a news report with disturbing information. In some women, the drug made their cancer more aggressive and more likely to spread. Other women with breast cancer, the report stated, do not respond to Tamoxifen at all, and 30 to 40 percent of women who take the drug eventually become resistant to chemotherapy. The woman contacted her oncologist to ask some questions:
How can some people react one way to a cancer treatment and others react a different way?
Case summary:
A middle-aged woman was taking Tamoxifen drug as breast cancer treatment for 10 years. One day she came across a disturbing news, which said that different response was seen in different patients as this drug made cancer more aggressive and metastasize in the rest of the body in some patients. While other woman did not respond to the drug and 30–40% of women gradually became resistant to chemotherapy. The woman had some queries to be asked by her oncologist.
Characters in the case:
A middle-aged woman suffering from breast cancer for 10 years.
Adequate information:
The news report points out the different response of the patients to breast cancer treatment, in which some patient’s cancer has aggravated, few others do not show any response to the treatment, and around 40% have become resistant to chemotherapy.
To determine:
The reason for the different responses by different individuals for the drug to cancer treatment.
Explanation of Solution
Given information:
The drug for cancer shows variation in response in different group of individuals.
All the drugs designed for cancer treatment are DNA (deoxyribonucleic acid) damaging. The uncontrolled proliferation of cell is due to mutated DNA, which has to be destructed in order to inhibit tumor growth.
Pharmacogenomics is the field that studies the interaction of medicine with inherited genes. Although the same chemical agent is used as a drug for cancer therapy in all patients, even then different patients react differently to it, the following could be the reasons:
1. The different individual possesses different gene composition: The basic genome structure of all the individuals are same but the great diversity between the individuals of the same species is introduced due to 0.1% difference in genetic makeup. Thus, different cell lines react differently to the same drug.
2. The difference in the rate of metabolism: Different individuals have a different rate of metabolism. Few individuals may break down the drug fast as compared to another individual, making the treatment successful. Another individual may gradually metabolize the drug and the drug may persist for a long time in their body, this would not only cause adverse side effects but also may not give any response to the treatment.
3. The difference in drug activation and deactivation: On receiving a particular drug, certain enzymes are synthesized in the body, which helps in the activation of this drug but the drug activation does not occur in all the individuals. Similarly, drugs also need to undergo deactivation to inhibit the exposure to the healthy cells and limit the side effect of the drug.
4. The difference in DNA repair pathway: Once the DNA-damaging drugs are introduced, the cells will defend itself against the damage of DNA caused by chemotherapeutic drugs. The defense mechanism of cells includes DNA repair and other pathways but due to the difference in genetic makeup, every individual will have a slight variation among the genes involved in these pathways.
Therefore, it can be concluded that the basic composition of the genome is same in each and every individual but the great diversity, which is seen among individuals of same species, occurs due to a slight difference in the genetic makeup. The difference in response to cancer treatment is due to this difference in cell line or genes.
Want to see more full solutions like this?
Chapter 16 Solutions
Essentials of Genetics (9th Edition) - Standalone book
- I understand how nuclear factor-kB (NFKB) works in the inflammatory response but what is the mechanism by which it causes cancer?arrow_forwardOut of these 8 hallmarks ( sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, activating invasion and metastasis, deregulating cellular energetics and metabolism, and avoiding immune destruction). Rank them from least important to most for cancer development. Explain in 2-3 sentences how.arrow_forward-Describe the seven hallmarks of cancer i) List the seven hallmarks ii) Connect each hallmark to the type of change -Explain importance of p53 i) Know the function of p53 ii) Explain how loss of p53 can result in several hallmarks of cancerarrow_forward
- Name the six fundamental properties of malignant tumours. Which of these properties are amenable to study in a cell culture model of cancer and why?arrow_forwardRetinoblastoma: The Hits Just Keep Coming 1.a There are three broad categories of cancer-related genes: proto-oncogenes, tumor suppressor genes, and DNA repair/stability genes. Distinguish between these three groups, then indicate which you think RB1 belongs to. b. In 1971, Alfred Knudson noticed that children like Kay, who have retinoblastoma in both eyes (bilateral), presented at earlier ages than those who had unilateral disease. To explain these different disease kinetics, he proposed the “two-hit hypothesis.” What does this hypothesis propose? c. Consider Dr. Whitt’s comments about the relationship between the wild-type and mutant RB1 alleles and what you now know about Knudson’s two-hit hypothesis. Do these ideas seem to confirm or contradict your earlier prediction (based on the pedigree) about whether the mutant RB1 allele is dominant or recessive to the wild-type allele? Explain. d. Do you think that Kay (and Julie) will be more likely to develop other cancers later in life?arrow_forward. Download and read the attached review article (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836099/pdf/EMBR-19-e45440.pdf) titled: Perturbing mitosis for anti-cancer therapy: is cell death the only answer?arrow_forward
- Briefly summarize the conventional wisdom (DNA mutation theory) of the cause of cancer. Discuss the treatments and side effects of these treatments that are based on the DNA mutation theory.arrow_forwardJurkat cells are an immortalized line of human T-lymphocytes cells that are used to study acute T cell leukemia. K562 cells were the first human immortalized myelogenous leukemia cell line to be established. Resting= control, Etoposide= drug. Below is shown the results of floweytometry of untreated and treated cells.arrow_forwardLung cancer mitotic index: 0.25 Breast cancer mitotic index: 0.35 Skin cancer mitotic index: 0.4 Looking at the mitotic index for all 3 cancer types, which one is likely to be the most resistant (least affected) to the growth-inhibiting effects of traditional chemotherapy drugs that target rapidly dividing cells?arrow_forward
- The growth fraction of the cancer types A 8, C, and D are 23%, 45%, 56%, and 78%, respectively. Which type of cancer is more suceptible to the chemotherapy?arrow_forwardDespite all that we know about cancer today, some types of cancers are still increasing in frequency. Lung cancer among nonsmoking women is one of these. What reason(s) might there be for this increasing problem?arrow_forwardHello! My question is: Discuss the evidence used to establish the causal association between virus infection and cancer. How can this knowledge be used in the diagnosis, treatment and prevention of virus-associated tumours? Thank you!!!!arrow_forward
- Biology 2eBiologyISBN:9781947172517Author:Matthew Douglas, Jung Choi, Mary Ann ClarkPublisher:OpenStaxHuman Biology (MindTap Course List)BiologyISBN:9781305112100Author:Cecie Starr, Beverly McMillanPublisher:Cengage Learning